A Retrospective Analysis of Mycobacterium tuberculosis in a Tertiary Healthcare Facility in Jos, North Central Nigeria

References (27)

1. 1 Global Tuberculosis Report 2020 – Reflections on the Global TB burden, treatment and prevention efforts [DOI]
2. 2 Tuberculosis and Stigmatization: Pathways and Interventions [DOI]
3. 3 Glucocorticoid use, other associated factors, and the risk of tuberculosis [DOI]
4. 4 Direct Visualization of the Outer Membrane of Mycobacteria and Corynebacteria in Their Native State [DOI]
5. 5 Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment [DOI]
6. 6 Identification of Risk Factors for Extrapulmonary Tuberculosis [DOI]
7. 7 The history of tuberculosis: from the first historical records to the isolation of Koch’s bacillus [DOI]
8. 8 An epidemiological evaluation of risk factors for tuberculosis in South India: a matched case control study.
9. 9 Diabetes mellitus is strongly associated with tuberculosis in Indonesia.
10. 10 Does tuberculosis threaten our ageing populations? [DOI]
11. 11 Treatment outcome of tuberculosis patients under directly observed treatment in Addis Ababa, Ethiopia [DOI]
12. 12 Systematic Review of Pooling Sputum as an Efficient Method for Xpert MTB/RIF Tuberculosis Testing during the COVID-19 Pandemic [DOI]
13. 13 Gender differences in delays in diagnosis and treatment of tuberculosis [DOI]
14. 14 Treatment delay and fatal outcomes of pulmonary tuberculosis in advanced age: a retrospective nationwide cohort study [DOI]
15. 15 The burden of HIV on Tuberculosis patients in the Volta region of Ghana from 2012 to 2015: implication for Tuberculosis control [DOI]
16. 16 PREVALENCE OF TUBERCULOSIS, DRUG-RESISTANT TUBERCULOSIS AND HIV/TB CO-INFECTION IN ENUGU, NIGERIA. [DOI]
17. 17 Directly Observed Treatment Short-course (DOTS) for tuberculosis control program in Gambella Regional State, Ethiopia: ten years experience [DOI]
18. 18 Prevalence of rifampicin resistant tuberculosis and associated factors among presumptive tuberculosis patients in a secondary referral hospital in Lagos Nigeria [DOI]
19. 19 Therapeutic Drug Monitoring of Antimycobacterial Drugs in Patients with Both Tuberculosis and Advanced Human Immunodeficiency Virus Infection [DOI]
20. 20 Gender differences in delays in diagnosis and treatment of tuberculosis [DOI]
21. 21 Results at 30 months of a randomised trial of two 8-month regimens for the treatment of tuberculosis [DOI]
22. 22 Prevalence of rifampicin-resistant tuberculosis among patients previously treated for pulmonary tuberculosis in North-Western, Nigeria [DOI]
23. 23 Tuberculosis may be underestimated in Rwandan women [DOI]
24. 24 Tuberculosis should not be considered an AIDS-defining illness in areas with a high tuberculosis prevalence.
25. 25 Trends in HIV-related morbidity among patients admitted to a South Indian tertiary hospital between 1997 and 2003 [DOI]
26. 26 Tuberculosis in Jos, Nigeria: A 9-Year Review of Laboratory Report at the Jos University Teaching Hospital [DOI]
27. 27 COVID-19 and tuberculosis—threats and opportunities [DOI]

Cited by 1

Related research

• Extrapulmonary Tuberculosis of the Genitourinary System — shares topic coverage
• The Prevalence of Tuberculosis among BCG Vaccinated Individuals at the North West Region of Cameroon — shares topic coverage
• Bacterial and Fungal Contaminants in Mycobacterium tuberculosis Cultures at National Tuberculosis Referral Laboratory-Kampala — shares topic coverage
• Patterns of Initial Drug Resistance of Mycobacterium tuberculosis Isolates from Kashmir Valley, India — shares topic coverage
• Analyzing Different Acetyl Co-A Metabolizing Enzymes as Potential Drug Targets against Mycobacterium tuberculosis — shares topic coverage